April 25 (Reuters) - Gilead Sciences ( GILD ) reported a first-quarter loss on Thursday after taking a $3.9 billion charge for its recent acquisition of liver drug developer CymaBay Therapeutics, while revenue rose 5% on higher HIV, oncology and liver disease treatment sales. For full-year 2024, Gilead said it still expects product sales of $27.1 billion to $27.5 billion,...

04:04 PM EDT, 04/25/2024 (MT Newswires) -- Price: 172.16, Change: +14.21, Percent Change: +9.00 ...

(Reuters) - Alphabet announced its first-ever dividend of 20 cents per share on Thursday, returning capital when the Google parent is spending billions of dollars on data centers to catch up with rivals on generative artificial intelligence. Shares of the rose nearly 13% in trading after the bell. Alphabet also said it had authorized the repurchase of up to an...

04:01 PM EDT, 04/25/2024 (MT Newswires) -- Kraken Robotics ( KRKNF ) on Thursday said it is raising C$17.5 million in a bought deal public share offering. The company is selling and underwriting syndicate 18.4-million priced at C$0.95 each, while also granting a 15% over-allotment option. Kraken expects to use the net proceeds to facilitate its long term strategy, including...